Rise in POCT to Drive the Global IVD Market

‘Emergence of POCT as the most preferred segment among consumers will drive the global IVD market which will reach around US$ 79 Billion in 2018’, says RNCOS.

 

Noida, UP -- (ReleaseWire) -- 07/28/2014 -- In a bid to meet the demands of the growing ageing population, companies are now focusing heavily on Point of Care testing. Roche, the clear leader of the global POCT market recently earned the highest rank in consumer satisfaction for its ACCU-CHECK blood glucose meters. Similarly, companies like Alere are in the process of development of POC tests. The company recently announced the immediate availability of the Alere Determine HIV-1/2 Ag/Ab Combo test in US and also announced plans to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform.

According to our research study, “In-Vitro Diagnostics Market Outlook 2018”, this rising interest in POCT will drive the global IVD market in the future. In the report, RNCOS analysts identified market dynamics in various regions to highlight areas such as POCT that offer promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.

The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and player specializations and for every segment a current and future outlook to 2018 has been provided. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.

The study further delves into the business dynamics of major players in the industry that together form around 80% of the global IVD market. To provide a thorough understanding of the Company’s business model, Company’s current and historical financials have been analyzed. Also, the Company’s revenue from IVD has been depicted with a further breakup by clinical segment. The study also portrays some of the profiled Company’s strengths and weaknesses that will help the reader to better position their company vis-à-vis competition.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM679.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.